Harvard Medical School Researcher Receives Prestigious 2025 Gairdner Award
Spyros Artavanis-Tsakonas recognized for research on fundamental cell signaling pathway
Spyros Artavanis-Tsakonas recognized for research on fundamental cell signaling pathway
More efficient and authentic cell creation enables immune studies, drug development
Using this method, scientists discovered key protein and gene activity changes in aging and in a rare disease called progeria.
Gene-editing technologies developed by Harvard’s David Liu demonstrate game-changing potential in two recent cases.
Nicole Maestas on how cuts threaten quality, sustainability of care
Deep-learning algorithm analyzes snapshots for information that could help oncologists tailor treatment intensity.
Molecular imaging reveals mechanism for resistance to immune checkpoint blockade
Julia Merkenschlager explores how secrets of natural immunity can improve vaccines, treatment
Study solves riddle of how mutations in Integrator complex relate to neurodegeneration, cancer
AI model EVE-Vax provides valuable clues about how a virus may evolve
147 students in HMS-based programs receive doctoral degrees amid turbulent times for U.S. research